Machine learning approaches to optimize small-molecule inhibitors for RNA targeting
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2946
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Machine learning approaches to optimize small-molecule inhibitors for RNA targeting ; volume:14 ; number:1 ; day:2 ; month:2 ; year:2022 ; pages:1-15 ; date:12.2022
Journal of cheminformatics ; 14, Heft 1 (2.2.2022), 1-15, 12.2022
- Urheber
-
Grimberg, Hadar
Tiwari, Vinay S.
Tam, Benjamin
Gur-Arie, Lihi
Gingold, Daniela
Polachek, Lea
Akabayov, Barak
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13321-022-00583-x
- URN
-
urn:nbn:de:101:1-2022051121425403053407
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Grimberg, Hadar
- Tiwari, Vinay S.
- Tam, Benjamin
- Gur-Arie, Lihi
- Gingold, Daniela
- Polachek, Lea
- Akabayov, Barak
- SpringerLink (Online service)
Ähnliche Objekte (12)
6 Small-Molecule Motion
Development of novel small-molecule inhibitors targeting the HGF/MET pathway
Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity
Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals
Cyclobutanes in Small‐Molecule Drug Candidates
Small-molecule modifiers for DNA nanostructures
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy
Small-Molecule Donor/Polymer Acceptor Type Organic Solar Cells: Effect of Terminal Groups of Small-Molecule Donors
6 Small-Molecule Motion
Development of novel small-molecule inhibitors targeting the HGF/MET pathway
Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity
Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals
Cyclobutanes in Small‐Molecule Drug Candidates
Small-molecule modifiers for DNA nanostructures
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy
Small-Molecule Donor/Polymer Acceptor Type Organic Solar Cells: Effect of Terminal Groups of Small-Molecule Donors
6 Small-Molecule Motion
Development of novel small-molecule inhibitors targeting the HGF/MET pathway
Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity
Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals
Cyclobutanes in Small‐Molecule Drug Candidates
Small-molecule modifiers for DNA nanostructures
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy